HK1119953A1 - Process for the stereoselective preparation of (-)-halofenate and intermediates thereof - Google Patents
Process for the stereoselective preparation of (-)-halofenate and intermediates thereofInfo
- Publication number
- HK1119953A1 HK1119953A1 HK08114045.8A HK08114045A HK1119953A1 HK 1119953 A1 HK1119953 A1 HK 1119953A1 HK 08114045 A HK08114045 A HK 08114045A HK 1119953 A1 HK1119953 A1 HK 1119953A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- halofenate
- intermediates
- stereoselective preparation
- stereoselective
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72030005P | 2005-09-23 | 2005-09-23 | |
US11/525,200 US7714131B2 (en) | 2005-09-23 | 2006-09-20 | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |
PCT/US2006/036928 WO2007038243A1 (fr) | 2005-09-23 | 2006-09-21 | Procede de preparation stereoselective de (-)-halofenates et d'intermediaires de ces derniers |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1119953A1 true HK1119953A1 (en) | 2009-03-20 |
Family
ID=37894903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08114045.8A HK1119953A1 (en) | 2005-09-23 | 2008-12-29 | Process for the stereoselective preparation of (-)-halofenate and intermediates thereof |
Country Status (18)
Country | Link |
---|---|
US (1) | US7714131B2 (fr) |
EP (1) | EP1940387B1 (fr) |
JP (1) | JP2009515817A (fr) |
KR (1) | KR101309605B1 (fr) |
AU (1) | AU2006294950A1 (fr) |
BR (1) | BRPI0616188A2 (fr) |
CA (1) | CA2623350C (fr) |
DK (1) | DK1940387T3 (fr) |
EA (1) | EA015673B1 (fr) |
ES (1) | ES2394973T3 (fr) |
HK (1) | HK1119953A1 (fr) |
HR (1) | HRP20130001T1 (fr) |
IL (1) | IL190325A (fr) |
PL (1) | PL1940387T3 (fr) |
PT (1) | PT1940387E (fr) |
RS (1) | RS52608B (fr) |
SI (1) | SI1940387T1 (fr) |
WO (1) | WO2007038243A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009121940A1 (fr) * | 2008-04-03 | 2009-10-08 | Janssen Pharmaceutica Nv | Procédé de préparation de l'ester 2-acétylamino-éthylique de l'acide (-)-(4-chlorophényl)-(3-trifluorométhylphénoxy)-acétique |
EP2298729A4 (fr) * | 2008-06-03 | 2012-12-19 | Kaneka Corp | Procédé de production d un dérivé d acide aminé optiquement actif |
US9060987B2 (en) | 2011-11-04 | 2015-06-23 | Cymabay Therapeutics, Inc. | Methods for treating gout flares |
US9023856B2 (en) | 2011-11-04 | 2015-05-05 | Cymabay Therapeutics, Inc. | Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent |
WO2021236395A1 (fr) | 2020-05-18 | 2021-11-25 | Cymabay Therapeutics, Inc. | Sel de choline cb-0406 |
WO2021236394A1 (fr) | 2020-05-18 | 2021-11-25 | Cymabay Therapeutics, Inc. | Sel de trométhamine cb-0406 |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3444299A (en) * | 1964-02-07 | 1969-05-13 | American Cyanamid Co | Methods for the control and prevention of helminths with phenylbenzothiazolium compounds |
GB1097053A (en) * | 1964-03-16 | 1967-12-29 | Dow Chemical Co | Substituted benzothiazolium compounds and complexes thereof for use in animal husbandry |
US3517051A (en) * | 1964-03-20 | 1970-06-23 | Merck & Co Inc | Phenoxy substituted phenylacetic acids |
US3378582A (en) | 1964-03-20 | 1968-04-16 | Merck & Co Inc | (alpha-phenoxy)-and (alpha-phenylthio)-omegaphenyl-alkanoic acids |
US3517050A (en) * | 1966-10-03 | 1970-06-23 | Merck & Co Inc | Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid |
NL6712585A (fr) | 1966-10-03 | 1968-04-04 | ||
US3558778A (en) * | 1966-10-27 | 1971-01-26 | Dow Chemical Co | Methods and compositions for use in animal husbandry |
US3674836A (en) * | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
BE754245A (fr) * | 1969-08-01 | 1970-12-31 | Sumitomo Chemical Co | Derives d'acides phenoxy carboxyliques |
DK133742B (da) | 1970-10-30 | 1976-07-12 | Merck & Co Inc | Fremgangsmåde til fremstilling af 2-acetamidoethyl-(3-trifluormethylphenoxy)-(4-chlorphenyl)-acetat. |
US3923855A (en) * | 1972-07-13 | 1975-12-02 | Merck & Co Inc | 2-sulfonyloxyethyl 3-trifluoromethylphenoxy-4{40 -chlorophenyl acetate |
US3860628A (en) * | 1972-07-13 | 1975-01-14 | Merck & Co Inc | Cyanomethyl(3-trifluoromethylphenoxy)(4-chlorophenyl)acetate |
US3953490A (en) * | 1972-07-13 | 1976-04-27 | Merck & Co., Inc. | Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile |
NL7309571A (fr) | 1972-07-28 | 1974-01-30 | ||
US4110351A (en) * | 1973-04-02 | 1978-08-29 | Richardson-Merrell Inc. | Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts |
US3876791A (en) * | 1973-11-30 | 1975-04-08 | Uniroyal Inc | Control of acarids using certain benzothiazoles or benzothiazolines |
US4001268A (en) * | 1974-08-07 | 1977-01-04 | The United States Of America As Represented By The Secretary Of The Air Force | Substituted phenyl-benzimidazo compounds |
IL48707A0 (en) * | 1974-12-30 | 1976-02-29 | Synthelabo | Novel phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them |
JPS6039072B2 (ja) | 1976-07-28 | 1985-09-04 | 藤沢薬品工業株式会社 | N−置換フエニルアミノ脂肪酸誘導体 |
JPS5371071A (en) | 1976-12-08 | 1978-06-24 | Teijin Ltd | Alpha-phenoxyacetic acid derivs. |
US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
US4214095A (en) * | 1979-01-25 | 1980-07-22 | Siegfried Aktiengesellschaft | Chlorobenzyl phenoxy alkoxylates |
SE8003278L (sv) * | 1979-05-04 | 1980-11-05 | Continental Pharma | Fenyletylaminderivat |
US4532135A (en) * | 1981-02-09 | 1985-07-30 | Edwards K David G | Renoprotective treatments employing vasodilator compounds |
US4508882A (en) * | 1981-08-24 | 1985-04-02 | Asahi Glass Company Ltd. | Benzotriazole compound and homopolymer or copolymers thereof |
EP0077938A3 (fr) | 1981-10-23 | 1983-08-24 | Mitsubishi Kasei Corporation | Tétrahydrophtalimides N-(3-substituées aminophényl) et compositions herbicides les contenant |
DE3236730A1 (de) | 1982-10-04 | 1984-04-05 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von benzoxazolyl- und benzthiazolyloxyphenoxypropionsaeurederivaten |
US4528311A (en) * | 1983-07-11 | 1985-07-09 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles |
JPS60109578A (ja) | 1983-11-17 | 1985-06-15 | Mitsubishi Chem Ind Ltd | 3−(置換フエニル)−5−置換−1,3,4−オキサゾリン−2−オン類およびこれを有効成分とする除草剤 |
DE3525284A1 (de) * | 1985-07-16 | 1987-01-29 | Boehringer Mannheim Gmbh | Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten |
US4714762A (en) * | 1986-10-31 | 1987-12-22 | Warner-Lambert Company | Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof |
US4786731A (en) * | 1987-08-05 | 1988-11-22 | The Dow Chemical Company | Resolution of enantiomers of 2-(phenyl or phenoxy/propionic acids using optically active alkanolamines |
JPH0670025B2 (ja) | 1987-08-07 | 1994-09-07 | 鐘紡株式会社 | ベンゾチアゾ−ル誘導体および該化合物を有効成分とする抗リウマチ剤 |
GB8720365D0 (en) * | 1987-08-28 | 1987-10-07 | Sandoz Ltd | Organic compounds |
US4863802A (en) * | 1987-12-31 | 1989-09-05 | General Electric Company | UV-stabilized coatings |
JPH01305069A (ja) * | 1988-05-31 | 1989-12-08 | Shionogi & Co Ltd | ベンゾトリアゾール誘導体およびそれを含有する発螢光試薬 |
CA2034309C (fr) * | 1990-01-22 | 1997-04-01 | Takashi Iwaki | Compose mesomorphe, composition de type cristal liquide qui en contient, dispositif a cristal liquide qui utilise ce compose et appareillage d'affichage |
US5278314A (en) * | 1991-02-12 | 1994-01-11 | Ciba-Geigy Corporation | 5-thio-substituted benzotriazole UV-absorbers |
DE4111026A1 (de) | 1991-04-05 | 1992-10-08 | Boehringer Mannheim Gmbh | Optisch aktive carbonsaeuren sowie diese enthaltende arzneimittel |
US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
ATE149481T1 (de) * | 1992-03-09 | 1997-03-15 | Hoechst Ag | Vereinfachende verfahren zur herstellung von vinylglycin (2-aminobut-3-ensäure) und passende auflösung von einem derivat |
DE4303676A1 (de) * | 1993-02-09 | 1994-08-11 | Bayer Ag | 1-Aryltriazolin(thi)one |
US5874431A (en) * | 1993-08-28 | 1999-02-23 | Cancer Research Campaign Technology Limited | Benzazole compounds |
US5496826A (en) * | 1994-09-02 | 1996-03-05 | Bristol-Myers Squibb Company | Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides |
US5455152A (en) * | 1994-09-27 | 1995-10-03 | Eastman Kodak Company | Benzotriazole based UV absorbing monomers and photographic elements containing polymers formed from them |
US5700819A (en) * | 1994-11-29 | 1997-12-23 | Grelan Pharmaceutical Co., Ltd. | 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications |
EP0748326B1 (fr) * | 1994-12-28 | 2001-07-04 | Rhodia Chimie | Diphosphines optiquement actives, leur preparation par dedoublement du melange racemique |
GB9503946D0 (en) * | 1995-02-28 | 1995-04-19 | Cancer Res Campaign Tech | Benzazole compounds |
US5500332A (en) * | 1995-04-26 | 1996-03-19 | Eastman Kodak Company | Benzotriazole based UV absorbers and photographic elements containing them |
US5708186A (en) * | 1995-12-12 | 1998-01-13 | Merck & Co Inc | Stereoselective process |
US6242464B1 (en) * | 1996-01-22 | 2001-06-05 | Chiroscience Limited | Single isomer methylphenidate and resolution process |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US5766834A (en) * | 1996-05-17 | 1998-06-16 | Eastman Kodak Company | Photographic element containing ultraviolet absorbing polymer |
US5716987A (en) * | 1996-06-21 | 1998-02-10 | Bristol-Myers Squibb Company | Prophylactic and therapeutic treatment of skin sensitization and irritation |
AU4054197A (en) * | 1996-08-14 | 1998-03-06 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
IL129705A (en) * | 1996-11-22 | 2003-10-31 | Ciba Sc Holding Ag | Use of selected benzotriazole derivatives for protecting human and animal skin and hair from the harmful effects of uv radiation |
US5942532A (en) | 1997-09-05 | 1999-08-24 | Ortho Pharmaceutical Corporation | 2-substituted phenyl-benzimidazole antibacterial agents |
JP3271991B2 (ja) | 1997-11-07 | 2002-04-08 | 大鵬薬品工業株式会社 | ベンズイミダゾール誘導体及びその薬学的に許容される塩 |
WO1999062885A1 (fr) * | 1998-06-05 | 1999-12-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1-(4-aminophenyl) pyrazoles substitues et leur utilisation en tant qu'agents anti-inflammatoires |
US6013659A (en) * | 1998-09-04 | 2000-01-11 | University Of Pittsburgh | Methods of reducing tumor colony number using novel benzothiazole compounds |
DE19844876A1 (de) * | 1998-09-30 | 2000-04-06 | Basf Ag | Verfahren zur Racematspaltung von Arylalkylcarbonsäureestern |
IN189741B (fr) * | 1998-11-09 | 2003-04-19 | Council Scient Ind Res | |
AU779117B2 (en) | 1998-12-18 | 2005-01-06 | Axys Pharmaceuticals, Inc. | Protease inhibitors |
US6624194B1 (en) * | 1999-06-04 | 2003-09-23 | Metabolex, Inc. | Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US7576131B2 (en) * | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US6262118B1 (en) | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
CN1167680C (zh) | 1999-12-27 | 2004-09-22 | 日本烟草产业株式会社 | 稠环化合物及其药物用途 |
WO2004078113A2 (fr) * | 2003-03-04 | 2004-09-16 | Pharmacia Corporation | Traitement et prevention de l'obesite au moyen d'inhibiteurs de cox-2 seul ou en combinaison avec des agents d'amaigrissement |
US7199259B2 (en) * | 2003-06-20 | 2007-04-03 | Metabolex, Inc. | Resolution of α-(phenoxy)phenylacetic acid derivatives |
RS20050937A (en) | 2003-06-20 | 2008-04-04 | Metabolex Inc., | Resolution of alpha- (phenoxy)phenylacetic acid derivatives |
-
2006
- 2006-09-20 US US11/525,200 patent/US7714131B2/en not_active Expired - Fee Related
- 2006-09-21 EA EA200800884A patent/EA015673B1/ru not_active IP Right Cessation
- 2006-09-21 ES ES06815150T patent/ES2394973T3/es active Active
- 2006-09-21 JP JP2008532404A patent/JP2009515817A/ja not_active Withdrawn
- 2006-09-21 RS RS20130001A patent/RS52608B/en unknown
- 2006-09-21 PL PL06815150T patent/PL1940387T3/pl unknown
- 2006-09-21 PT PT68151505T patent/PT1940387E/pt unknown
- 2006-09-21 AU AU2006294950A patent/AU2006294950A1/en not_active Abandoned
- 2006-09-21 EP EP06815150A patent/EP1940387B1/fr active Active
- 2006-09-21 WO PCT/US2006/036928 patent/WO2007038243A1/fr active Application Filing
- 2006-09-21 BR BRPI0616188-0A patent/BRPI0616188A2/pt not_active IP Right Cessation
- 2006-09-21 KR KR1020087009709A patent/KR101309605B1/ko not_active IP Right Cessation
- 2006-09-21 CA CA2623350A patent/CA2623350C/fr not_active Expired - Fee Related
- 2006-09-21 SI SI200631502T patent/SI1940387T1/sl unknown
- 2006-09-21 DK DK06815150.5T patent/DK1940387T3/da active
-
2008
- 2008-03-20 IL IL190325A patent/IL190325A/en not_active IP Right Cessation
- 2008-12-29 HK HK08114045.8A patent/HK1119953A1/xx not_active IP Right Cessation
-
2013
- 2013-01-02 HR HRP20130001TT patent/HRP20130001T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
IL190325A0 (en) | 2009-09-22 |
HRP20130001T1 (hr) | 2013-02-28 |
AU2006294950A1 (en) | 2007-04-05 |
EA015673B1 (ru) | 2011-10-31 |
CA2623350A1 (fr) | 2007-04-05 |
SI1940387T1 (sl) | 2013-04-30 |
DK1940387T3 (da) | 2013-01-02 |
EP1940387B1 (fr) | 2012-11-28 |
JP2009515817A (ja) | 2009-04-16 |
RS52608B (en) | 2013-04-30 |
PT1940387E (pt) | 2012-12-17 |
PL1940387T3 (pl) | 2013-02-28 |
EP1940387A1 (fr) | 2008-07-09 |
IL190325A (en) | 2013-04-30 |
US7714131B2 (en) | 2010-05-11 |
EP1940387A4 (fr) | 2010-11-03 |
US20070072858A1 (en) | 2007-03-29 |
KR101309605B1 (ko) | 2013-09-17 |
KR20080050527A (ko) | 2008-06-05 |
CA2623350C (fr) | 2014-08-19 |
BRPI0616188A2 (pt) | 2011-06-14 |
EA200800884A1 (ru) | 2008-12-30 |
WO2007038243A1 (fr) | 2007-04-05 |
ES2394973T3 (es) | 2013-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL256157A (en) | A method of making an isolated uricase enzyme with modifications | |
ZA200710163B (en) | Methods of preparing 3-cyano-quinolines and intermediates made thereby | |
IL188201A0 (en) | Processes for the manufacture of rosuvastatin and intermediates | |
IL202664A (en) | Processes for Preparation of 3-Dihlomethyl-1-Methyl-1H-Pyrazole-4-Carbaldehyde and Intermediates | |
IL187532A0 (en) | Methods of synthesizing substituted 3- cyanoquinolines and intermediates thereof | |
PT2308825E (pt) | Processo para a preparação de um intermediário para a azoxistrobina | |
IL188919A (en) | Process for the preparation of mandipropamide and its derivatives as well as its intermediates | |
IL185627A (en) | A process for making alkyl-anilides and their intermediates | |
IL197954A0 (en) | Process for the preparation of imatinib and intermediates thereof | |
IL185129A0 (en) | Process for making montelukast and intermediates therefor | |
PL1968996T3 (pl) | Sposób wytwarzania żelazo-sukcynylokazeiny | |
PL1937626T3 (pl) | Sposób i związki do otrzymywania salmeterolu | |
HUP0500537A2 (en) | Process for the preparation of rosuvastatin via new intermediates | |
IL184715A0 (en) | Process for the preparation of intermediates | |
EP1853559A4 (fr) | Procédé amélioré pour la préparation d'atorvastatine et intermédiaires pour celui-ci | |
HK1119953A1 (en) | Process for the stereoselective preparation of (-)-halofenate and intermediates thereof | |
IL200850A0 (en) | Process for the preparation of entacapone and intermediates thereof | |
ZA200601910B (en) | Process for the preparation of organosilances | |
SI2044099T1 (sl) | Postopek priprave S-fluorometil-6,9-difluoro-11-hidroksi-16-metil-17-propioniloksi-3-okso -androsta-1,4-dien-17-karbotioata in vmesnih spojin | |
IL188898A0 (en) | Processes for preparing pyrazol-o-glycoside derivatives and novel intermediates of said processes | |
IL187832A0 (en) | Methods and intermediates for the preparation of optionally radio- labeled imatinib | |
ZA200803329B (en) | Process for the stereoselective preparation of (-)-halofenate and intermediates thereof | |
ZA200706872B (en) | Process for making montelukast and intermediates therefor | |
HU0401379D0 (en) | Process for the preparation of risperidon | |
HUP0600946A2 (en) | Process for the preparation of duloxetine and the new intermediates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180921 |